Head-to-head comparison
OrderlyMeds vs SnagRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.
$74/mo (promo rate) sema · $299/mo tirz · Verified August 2026
Marked down on: The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.
Desk Score
SnagRx is a cash-pay GLP-1 telehealth service from Modern Metabolic Medicine, Inc.
$69/mo (promo rate) sema · $119/mo (promo rate) tirz · Verified August 2026
Marked down on: The "Was $299/$399" anchor has not been charged in any of our three checks, and the promotional rate itself has now moved twice — $99/$149 on 2026-06-19, still $99/$149 on 2026-08-11, and $69/$119 on 2026-08-29, always with the same anchor and the same expiring countdown. A rate that falls twice in ten weeks is not "locked-in flat pricing for life"
SnagRx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 64/100 (C) for OrderlyMeds. OrderlyMeds still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
OrderlyMeds
64/100
C
SnagRx
77/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | OrderlyMeds | SnagRx |
|---|---|---|
| Semaglutide | $74/mopromo rate$74/mo (starting dose, 2-mo starter plan, new patients only, compounded) | $69/mopromo rate$69/mo (Summer Start promotional rate, flat at every dose, compounded) |
| Tirzepatide | $299/mo$299/mo (compounded) | $119/mopromo rate$119/mo (Summer Start promotional rate, flat at every dose, compounded) |
| Coverage | Not listed on OrderlyMeds's site (checked August 2026) | All 50 states plus Washington D.C. (per Terms) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | A first GLP-1 course at a published starter rate, with the standing rate published beside it. | Compounded semaglutide and tirzepatide at a flat lifetime price. |
| Desk Score | 64/100C | 77/100C+ |
The verdict
Desk pick — SnagRxSnagRx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 64/100 (C) for OrderlyMeds. OrderlyMeds still holds its ground where its strengths line up with yours.
Choose OrderlyMeds if…
A first GLP-1 course at a published starter rate, with the standing rate published beside it.
$74/mo (promo rate) sema · $299/mo tirz
FDAWarning letter issued to OrderlyMeds LLC dba OrderlyMeds in June 2026. See the FDA warning-letter database.
Choose SnagRx if…
Compounded semaglutide and tirzepatide at a flat lifetime price.
$69/mo (promo rate) sema · $119/mo (promo rate) tirz · All 50 states plus Washington D.C. (per Terms)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: OrderlyMeds · SnagRx.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs OrderlyMeds
- CoreAge Rx vs SnagRx
- OrderlyMeds vs yourEra
- SnagRx vs Tyde Wellness
- OrderlyMeds vs Sunlight
- SnagRx vs yourEra
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.